USP-, EP-, BP-, and JP-grade

USP-, EP-, BP-, and JP-grade refer to pharmaceutical standards set by different pharmacopoeias: the United States Pharmacopoeia (USP), the European Pharmacopoeia (EP), the British Pharmacopoeia (BP), and the Japanese Pharmacopoeia (JP). Each pharmacopoeia defines specific standards for the quality, purity, and characteristics of drugs and other pharmaceutical substances. These standards help ensure the safety and efficacy of pharmaceutical products in their respective regions.


USP-grade (US Pharmacopoeia)

USP-grade refers to a standard set by the United States Pharmacopeia (USP), a non-profit organisation that establishes quality and purity standards for drugs, food ingredients, and dietary supplements. It develops and publishes standards to ensure the identity, quality, purity, strength, and consistency of these products. While the USP is a U.S.-based organisation, its standards are recognized and used globally. Many countries and international organisations refer to USP standards as a benchmark for quality in pharmaceuticals and related products.

EP-Grade (European Pharmacopoeia)

The European Pharmacopoeia (EP) stands as a critical reference in the European pharmaceutical landscape, under the oversight of the European Directorate for the Quality of Medicines & HealthCare (EDQM). Predominantly utilized within European countries, the EP serves as a comprehensive guide to ensure the quality of pharmaceuticals. Its stringent standards cover pharmaceutical substances, excipients, and dosage forms, specifying criteria for identity, purity, strength, and overall quality. Compliance with EP standards is pivotal for companies seeking marketing authorization and facilitating seamless trade within the European Economic Area.

JP-Grade (Japanese Pharmacopoeia)

Regulated by the Ministry of Health, Labour and Welfare in Japan, the Japanese Pharmacopoeia (JP) serves as the official pharmacopoeia in the country. The JP holds primary significance in Japan's pharmaceutical sector and provides standards for the quality and specifications of drugs, excipients, and medicinal products. Notably, the JP encompasses guidelines for traditional Japanese medicines, reflecting the rich diversity of Japan's pharmaceutical heritage. Its specifications and regulations are instrumental in ensuring the safety and efficacy of pharmaceuticals within the Japanese market.

BP-Grade (British Pharmacopoeia)

The British Pharmacopoeia (BP), curated and published by the British Pharmacopoeia Commission, holds paramount importance in the United Kingdom's pharmaceutical landscape. While primarily applied within the UK, the BP has found adoption in several other countries. Focused on maintaining the quality and purity of medicinal products, including pharmaceutical substances, excipients, and formulations, the BP's standards play a crucial role in upholding the integrity of medicines. Adherence to BP standards is imperative for pharmaceutical manufacturers operating within its jurisdiction.

Nedstar compliance

Nedstar offers products that comply with USP, BP, JP, and EP potency and purity standards for chemicals and solvents. A product that is approved as pharmaceutical-grade by these bodies can be used in food, drugs or medicinal products in those countries, as well as for most lab purposes.

Orange arrow pointing right iconOur products